Health Canada chief medical adviser Dr. Supriya Sharma said Wednesday that they were monitoring the pause of the Johnson & Johnson COVID-19 vaccine in the U.S. and had requested information on any potential cases of rare blood clots from the company. She added they were working with international partners to examine the cases and would take action if necessary.
Canada
Health Canada monitoring Johnson & Johnson pause in U.S., will take action if necessary
More Videos
-
Canada ‘blindsided’ by new U.S. border rules on dogs, Holland says
-
Torrential downpour exposes Toronto’s ageing infrastructure
-
Boissonnault’s former business partner claims autocorrect to blame for ‘Randy’ text messages
-
Under Trudeau, the civil service has grown twice as fast as Canada’s population
-
Lack of federal-provincial emergency preparedness has led to ‘missed opportunities,’ N.S. premier says
-
Operation Chrome: Peel police seize largest number of illegal firearms in region’s history
You are viewing an Accelerated Mobile Webpage.
View Original Article